These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11586807)

  • 41. Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa.
    Schoub BD; Matai U; Singh B; Blackburn NK; Levin JB
    Bull World Health Organ; 2002; 80(4):277-81. PubMed ID: 12075363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis-B vaccine introduction into the routine immunization schedule--Andhra Pradesh experience.
    Kiran V
    Indian J Public Health; 2004; 48(2):63-6. PubMed ID: 15709587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
    Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004).
    Sonder GJ; Bovée LP; Baayen TD; Coutinho RA; van den Hoek JA
    Vaccine; 2006 Jun; 24(23):4962-8. PubMed ID: 16675076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute exacerbation of chronic hepatitis B: yet another incentive to commence universal infant immunization even in low endemic areas.
    Lagging M
    Scand J Gastroenterol; 2008; 43(2):131. PubMed ID: 18224559
    [No Abstract]   [Full Text] [Related]  

  • 47. Parents' attitudes towards hepatitis B vaccination for their children. A survey comparing paper and web questionnaires, Sweden 2005.
    Dannetun E; Tegnell A; Giesecke J
    BMC Public Health; 2007 May; 7():86. PubMed ID: 17511891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
    Danielsson N; Fakakovikaetau T; Szegedi E
    Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B vaccination in children with juvenile idiopathic arthritis.
    Kasapçopur O; Cullu F; Kamburoğlu-Goksel A; Cam H; Akdenizli E; Calýkan S; Sever L; Arýsoy N
    Ann Rheum Dis; 2004 Sep; 63(9):1128-30. PubMed ID: 15308522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B vaccination coverage among adults--United States, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 May; 55(18):509-11. PubMed ID: 16691181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century.
    Yap SF
    Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East.
    Specialist Panel on Chronic Hepatitis B in the Middle East
    J Viral Hepat; 2012 Jan; 19(1):9-22. PubMed ID: 22187943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B: long-term outcome and benefits from mass vaccination in children.
    Chang MH
    Acta Gastroenterol Belg; 1998; 61(2):210-3. PubMed ID: 9658611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hepatitis B outbreak in a day care center affected several families. It could have been prevented by vaccination of all children].
    Broholm KA; Sjödin L; Backlund I; Johansson B; Norder H; Magnius L
    Lakartidningen; 2001 May; 98(19):2337-8, 2341-2. PubMed ID: 11402989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan.
    Kao JH; Hsu HM; Shau WY; Chang MH; Chen DS
    J Pediatr; 2001 Sep; 139(3):349-52. PubMed ID: 11562612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vaccination against hepatitis B should be offered to all children].
    Nersing U
    Lakartidningen; 1996 Apr; 93(16):1509-10. PubMed ID: 8667743
    [No Abstract]   [Full Text] [Related]  

  • 59. Vaccination against hepatitis B: current challenges for Asian countries and future directions.
    Safary A; Beck J
    J Gastroenterol Hepatol; 2000 Apr; 15(4):396-401. PubMed ID: 10824884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B.
    Wozniak TM; Smith M; Maher L
    N S W Public Health Bull; 2013 Nov; 24(2):94. PubMed ID: 24195855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.